NIH Funding Opportunities (Notices, PA, RFA)
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 10 min 21 sec ago
NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-017, "Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed)"
Notice NOT-HL-19-716 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
Funding Opportunity PAR-19-339 from the NIH Guide for Grants and Contracts. This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.
Categories: Job Watch, Literature Watch
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-340 from the NIH Guide for Grants and Contracts. This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.
Categories: Job Watch, Literature Watch
Notice of Special Interest: Selective Cell and Network Vulnerability in Aging and Alzheimers Disease
Notice NOT-AG-19-033 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-338 from the NIH Guide for Grants and Contracts. This FOA invites revision, resubmission, or renewal applications to the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement. Revision applications may not request funding beyond the project end date of the Parent award.
Categories: Job Watch, Literature Watch
Notice of NINR Withdrawal from Participation in PAR-19-335 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required"
Notice NOT-NR-19-009 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NINR Withdrawal from Participation in PAR-19-334 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed"
Notice NOT-NR-19-008 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NINR Withdrawal from Participation in PAR-19-333 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed"
Notice NOT-NR-19-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional)
Funding Opportunity RFA-HL-20-016 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to identify abnormalities in circadian-ordered gene expression to improve our understanding of disease phenotypes, etiology, risk stratification, resilience, and therapeutic management in diseases.
Categories: Job Watch, Literature Watch
Notice of Clarification for Suggested Tables for PAR-19-219 "Maximizing Access to Research Careers (T34)"
Notice NOT-GM-19-056 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification for Suggested Tables for PAR-19-218 Undergraduate Research Initiative for Student Enhancement (RISE) (T34)
Notice NOT-GM-19-055 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Funding Opportunity in PAR-19-244 "International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)"
Notice NOT-TW-19-006 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Award Budget for RFA-DA-19-020 " HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)"
Notice NOT-DA-19-067 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Award Budget for RFA-DA-19-019 " HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)"
Notice NOT-DA-19-057 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest: NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment
Notice NOT-CA-19-059 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend the Expiration Date of PAR-18-227, "Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)"
Notice NOT-MH-19-037 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of the Response Date for NOT-AT-19-030 "Request for Information (RFI): Important Considerations for Potential Creation of an Open-Access Repository or Database for Physiological and Anatomical Ontology of Acupoints"
Notice NOT-AT-19-031 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-044 from the NIH Guide for Grants and Contracts. This FOA invites applications on novel studies of the molecular mechanisms underlying metformins effects on aging and longevity. The goal of this FOA is to support applications that will lead to an in-depth understanding of the molecular mechanisms that determine the effects of metformin, either beneficial or detrimental, in relation to aging and longevity. Research supported by this FOA should lead to new insights and better understanding of metformins effects on aging and aging-related diseases.
Categories: Job Watch, Literature Watch
Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional)
Funding Opportunity RFA-HD-20-010 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage small businesses to collaborate with scientists and clinicians in the fields of female and male reproductive health, infertility, andrology, and/or gynecology to adapt discoveries in omics technologies such as genomics, epigenomics and metabolomics, as well as identification of disease biomarkers to the development of new devices, assays, digital apps, or technologies to improve the specificity of diagnosis and clinical care of infertility and to advance the application of precision medicine to reproductive health.
Categories: Job Watch, Literature Watch
Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)
Funding Opportunity PAR-19-337 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit competitive revision (formerly known as competitive supplement) applications from awardees with active Clinical and Translational Science Award (CTSA) Program hub awards (UL1) to support the demonstration, and/or dissemination, and/or implementation of highly innovative and impactful translational science projects that address the goals of the CTSA Program and are beyond the original scope of the approved parent project.
Categories: Job Watch, Literature Watch